[Changes in the thrombophilic status in patients with pre-eclampsia]

Area of Science:

• Obstetrics and Gynecology
• Hematology
• Cardiovascular Medicine

Background:

• Preeclampsia is a pregnancy complication characterized by high blood pressure.
• Understanding the interplay between coagulation, fibrinolysis, and blood pressure in preeclampsia is crucial for patient management.

Purpose of the Study:

• To evaluate changes in fibrinolysis and clotting inhibitors in preeclampsia patients.
• To explore the relationship between preeclampsia and blood pressure parameters.

Main Methods:

• Prospective study of 62 pregnant women at delivery, divided into preeclampsia and control groups.
• Analysis of blood pressure (DBP, SBP, MBP), hemoglobin (Hb), platelet count (Plt), lupus anticoagulant, anticardiolipin antibodies (ACA), antinuclear antibodies (ANA), fibronectin, D-dimer, protein S (PS), protein C (PC), and von Willebrand factor (vWF).

Main Results:

• Preeclampsia patients showed higher Hb, fibronectin, and D-dimer, with lower protein C.
• Fibronectin correlated with higher SBP, DBP, MBP, and Hb.
• Low total protein S was associated with high D-dimer and SBP.

Conclusions:

• Preeclampsia involves increased hemoconcentration and decreased clotting inhibitors (protein C) without a fibrinolytic response.
• Elevated fibronectin indicates a vasopressive effect, with blood pressure stratification linked to hemodynamic changes and thrombophilic states.